Spero Therapeutics (SPRO)
(Delayed Data from NSDQ)
$1.42 USD
-0.02 (-1.05%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $1.41 -0.01 (-0.70%) 6:56 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -0.07 |
EPS Last Quarter | 0.96 |
Last EPS Surprise | 633.33% |
ABR | 1.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.94 |
Next Year | -0.90 |
EPS (TTM) | 0.50 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 16.80M | 1.80M | 49.20M | 48.00M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 16.80M | 1.80M | 49.20M | 48.00M |
Low Estimate | 16.80M | 1.80M | 49.20M | 48.00M |
Year ago Sales | 2.07M | 2.72M | 103.78M | 49.20M |
Year over Year Growth Est. | 711.59% | -33.82% | -52.59% | -2.44% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.07 | -0.41 | -0.94 | -0.90 |
# of Estimates | 2 | 1 | 3 | 2 |
Most Recent Consensus | -0.12 | -0.41 | -0.90 | -0.90 |
High Estimate | -0.01 | -0.41 | -0.90 | -0.90 |
Low Estimate | -0.12 | -0.41 | -0.99 | -0.90 |
Year ago EPS | -0.25 | -0.23 | 0.43 | -0.94 |
Year over Year Growth Est. | 72.00% | -78.26% | -318.60% | 3.90% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 3 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.07 | -0.41 | -0.94 | -0.90 |
7 Days Ago | -0.07 | -0.41 | -0.94 | -0.90 |
30 Days Ago | -0.07 | -0.41 | -0.94 | -0.90 |
60 Days Ago | -0.34 | -0.32 | -0.60 | -0.78 |
90 Days Ago | -0.34 | -0.32 | -0.60 | -0.78 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.07 | -0.41 | -0.94 | -0.90 |
Zacks Consensus Estimate | -0.07 | -0.41 | -0.94 | -0.90 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.96 | 0.02 | -0.23 | -0.25 | NA |
Estimate | -0.18 | -0.15 | -0.29 | -0.35 | NA |
Difference | 1.14 | 0.17 | 0.06 | 0.10 | 0.37 |
Surprise | 633.33% | 113.33% | 20.69% | 28.57% | 198.98% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more